Table 2.
Comparative analysis of all measured variables for the EG and CG – the initial and final assessments
| Parameters | Statistics | EG (n=40)
|
P-value | CG (n=34)
|
P-value | ||
|---|---|---|---|---|---|---|---|
| Initial assessment | Final assessment | Initial assessment | Final assessment | ||||
|
| |||||||
| Myostatin concentration (ng/mL) | IQR | 38.69 | 48.57 | <0.0001* | 79.58 | 67.47 | 0.1852 |
| Med | 142.74 | 121.15 | 145.32 | 153.08 | |||
|
| |||||||
| RUIS (points) | IQR | 6.00 | 5.00 | <0.0001* | 7.00 | 5.00 | 0.1904 |
| Med | 8.00 | 6.00 | 8.00 | 9.00 | |||
Note:
*
Indicates statistical significance.
Abbreviations: EG, experimental group; CG, control group; Med, median; RUIS, Revised Urinary Incontinence Scale.